NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the …
![NeuroBo Pharmaceuticals Phase 2a Clinical Trial](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/istockphoto-1365131135-612x612-1.jpg?resize=612%2C408&ssl=1)
![NeuroBo Pharmaceuticals Phase 2a Clinical Trial](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/istockphoto-1365131135-612x612-1.jpg?resize=612%2C408&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the …